Oxford-founded biopharmaceutical development instrument manufacturer Refeyn has secured funding from the university and OSI to help scale manufacturing and distribution.

Ghent-founded indoor position technology business Pozyx has amassed more than $1.5m having recently completed the launch of its initial product range.

University of Virginia spectroscopy spinout BrightSpec has added series B capital from investors including the university's seed fund to an earlier $1.5m sum raised in 2015.

Russian Academy of Sciences spinout PM&HM has signed up a second government-owned vehicle to help commercialise its digitally-enabled inhaler for tuberculosis, cancer and HIV.

Conversational marketing tool developer Eyelevel.ai graduated from UC Berkeley’s SkyDeck in 2018 and has now secured a follow-on investment from the accelerator.

University of Michigan will supply an initial $2.75m in funding to MemryX, Ripple Science, GreenMark Biomedical, and Give and Take, and could invest as much as $20m altogether.

Cell conversion technology developer Mogrify's founding team includes representation from the universities of Bristol and Monash, as well as Duke University - NUS Medical School.

The liver disease diagnostics spinout has secured the first tranche of a $10m series A investment by Fosun Pharma initially announced in October 2018.

UBC and CDRD spinout Sitka Biopharma has now lured $5.5m in total and is readying its bladder cancer treatment for initial clinical trials.

Founded out of Massachusetts Institute of Technology, SendFriend has built a blockchain-powered online payment transfer platform that uses technology provided by fintech developer Ripple.